Analytical testing for recombinant and polyclonal antibody characterization and validation. Confirms antibody functionality and performance metrics prior to production scale-up.
Manufactured by
Changzhou Boyi Biological Group
China
Changzhou Boyi Biological Group is a technology company focused on the in-vitro diagnostics (IVD) industry, providing critical raw materials and comprehensive solutions for biomedical customers. Core products include diagnostic microspheres, detection reagents, and quality control materials. The company offers antigen/antibody screening, expression services, and complete IVD solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Nittobo America Inc.
United States · 1 relevant product
Fraunhofer Institute for Cell Therapy and Immunology IZI ASSESS-MED dialyzer test laboratory
Germany · 1 relevant product
Exonbio LLC.
United States · 1 relevant product
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 33 closest product alternatives
Nittobo America Inc. · United States
Contract polyclonal antibody production utilizing client antigens in USDA-licensed facilities for custom immunodiagnostic assay development.
Fraunhofer Institute for Cell Therapy and Immunology IZI ASSESS-MED dialyzer test laboratory · Germany
Quantification of plasma proteins and albumin-binding capacity in extracorporeal device testing. Assesses protein loss and binding characteristics of dialyzers and filters.
Exonbio LLC. · United States
Early-stage screening service employing standard ELISA and surface plasmon resonance methods for antibody characterization. Provides affinity ranking and preliminary validation of antigen-binding properties.
30 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products